Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for publishing professionals · Thursday, March 28, 2024 · 699,421,701 Articles · 3+ Million Readers

Cancer Immunotherapy Market is growing at a CAGR of 14.42% by 2025 - Progressive Markets

Progressive Markets published a report, titled, Cancer Immunotherapy Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2018-2025, which projects that the market was valued at $57,256.2 million in 2017 and is expected to reach $166,714.5 million by 2025

Pune, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Progressive Markets published a report, titled, Cancer Immunotherapy Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2018-2025, which projects that the market was valued at $57,256.2 million in 2017 and is expected to reach $166,714.5 million by 2025, registering a CAGR of 14.42% during 2018-2025.

Request Sample Report: https://www.progressivemarkets.com/request-sample/cancer-immunotherapy-market

The report aims to offer a comprehensive strategic analysis of the global cancer immunotherapy market along with the revenue and growth forecast for the period, 2018-2025. It includes the market size, share analysis, market segmentation, market forecast, drivers, restraints & opportunities, and key market players along with their profiles. The report is carefully compiled after an extensive gathering of information from industry-centric organizations which has been further endorsed by industry leaders. Bringing out the key insights of the industry, the report caters to various stakeholders, including market players, investors, industry leaders, and others, who wish to understand the latest trends, current market scenario, and latest technologies used in the industry.

The report provides information about the factors that drive or hamper the adoption of cancer immunotherapy. The market is driven by the rise in funding from various government and private organizations for carrying out R&D activities for cancer immunotherapy, growing occurrence of cancer globally, rise in approvals for the clinical trials and the growing acceptance of cancer immunotherapy are driving the demand of the industry. On the other hand, the high cost associated with cancer immunotherapy restrains the industry growth.

Get 20% Discount On Customization:

The report analyzes the global cancer immunotherapy market based on type, application, end user, and geography. Based on type, the market is classified into monoclonal antibodies, immunomodulators, cancer vaccines, and checkpoint inhibitors. The monoclonal antibodies segment is anticipated to grow at a CAGR of 14.79% during the forecast period. Based on application, the market is bifurcated into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, head and neck cancer, and others. The lung cancer segment is expected to garner $22,396.8 million while the breast cancer sector is likely to accrue a sum of $18,911.5 million by 2025. Based on end-user, the market is divided into hospitals, cancer research centers, and clinics. The hospitals sector is anticipated to reach $99,256.8 million by 2025. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. In North America, the market analysis is covered for the U.S., Canada, and Mexico. In Europe, the market analysis covers UK, Germany, France, Spain, Italy, and the rest of Europe. In Asia-Pacific, the market study covers the regions such as China, Japan, India, Australia, South Korea, and the rest of Asia-Pacific.

The report also includes the profiles of the leading players of the cancer immunotherapy market, including Novartis, AstraZeneca, Bristol-Myers Squibb, Amgen, F. Hoffman La-Roche, Eli Lilly and Company, Merck & Co., Inc., Janssen Global Services, LLC, Bayer AG, and Pfizer among others. The report discusses their product information, market size, market share, business strategies and much more to help analysis, investors and others interested in the market to take wise business decisions

Progressive Markets
                    4th Floor, Unit 12, Marisoft III,
                    West Wing, Marigold IT Park,
                    Kalyani Nagar, Pune, Maharashtra 411014,
                    India: +91 20 66346060
                    Toll Free: + 1-888-906-9222
                    help@progressivemarkets.com

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release